Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-2K015 is a novel Nectin-4-targeting peptide radioligand developed by Zonsen PepLib Biotech. It consists of the novel peptide ligand 2K015, which was discovered and optimized using PepLib's AI-driven in silico peptide design and disulfide-rich peptide phage display platform, conjugated to DOTA and radiolabeled with Gallium-68 (68Ga). 68Ga-2K015 exhibits picomolar binding affinity to human Nectin-4, a tumor-associated cell surface antigen highly expressed in urothelial carcinoma and other solid tumors. In preclinical evaluations, 68Ga-2K015 demonstrated high tumor uptake and favorable biodistribution, with lower kidney uptake compared to the benchmark comparator 68Ga-BT8009. In a human investigator-initiated trial (IIT) involving patients with urothelial carcinoma, 68Ga-2K015 achieved clear tumor imaging with low liver and kidney uptake, highlighting its potential as a diagnostic PET imaging tracer for Nectin-4-positive malignancies.
| Indication | Highest phase | Status |
|---|---|---|
| urothelial carcinoma of urinary tract | In development | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: urothelial carcinoma of urinary tract
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 68Ga-2K015.
Work on 68Ga-2K015? Claim this page to correct or add information. Claim this page